You, J., He, Y., Xu, M. et al. Sci Rep 14, 20573 (2024). https://doi.org/10.1038/s41598-024-71754-z Abstract Asthma is a prevalent chronic disease characterized by airflow obstruction, causing breathing difficulties and wheezing. This study investigates…
Yang W, Wang W, Ji Y, Pan H. J Asthma. 2024 Aug 28:1-10. doi: 10.1080/02770903.2024.2391441. Abstract Objective Asthma is a common chronic condition in children globally. Allergen-specific immunotherapy, such as…
Pesantes, E., Hernando, R., Lores, C. et al. BMC Pulm Med 24, 421 (2024). https://doi.org/10.1186/s12890-024-03227-y Abstract Background Fractional exhaled nitric oxide (FeNO) is used for the diagnosis and monitoring of asthma, although its…
Zhuang, H., Huang, X., Huang, H. et al. BMC Pulm Med 24, 419 (2024). https://doi.org/10.1186/s12890-024-03245-w Abstract Background Sleep disorders have a significant impact on asthma. The aim of this study was to explore…
Baxter, L., Cobo, M.M., Bhatt, A. et al. BMC Pulm Med 24, 412 (2024). https://doi.org/10.1186/s12890-024-03179-3 Abstract Background Ibuprofen is one of the most commonly used analgesic and antipyretic drugs in…
Emilsson ÖI, Johansson H, Johannessen A et al. ERJ Open Res. 2024 Aug 5;10(4):00071-2024. Abstract Aim Heritability of cough has not yet been studied. We aimed to evaluate if individuals with cough…
Robertshaw, M.J., Gorman, A., Glazer, C.S. et al. BMC Pulm Med 24, 398 (2024). https://doi.org/10.1186/s12890-024-03098-3 Abstract Background Antigen removal is a cornerstone of treatment of hypersensitivity pneumonitis (HP), but its association with transplant-free…
Canonica GW, Bagnasco D, Bondi B, Varricchi G, Paoletti G, Blasi F, Paggiaro P, Braido F; SANI study group. J Asthma. 2024 Jul 23:1-8. doi: 10.1080/02770903.2024.2376919. Abstract In the field…
Davis SR, Cvetkovski B, Katsoulotos GP, Lee JW, Rimmer J, Smallwood N, Tonga KO, Abbott P, Bosnic-Anticevich SZ. Int J Gen Med. 2024;17:3601-3611 Purpose: Severe asthma poses a significant health burden…
Jackson, David J. et al. European Respiratory Journal 64.1 (2024): 2301521. Abstract Background Pivotal phase 3 trials and real-world studies have demonstrated benralizumab’s overall efficacy and safety in severe eosinophilic asthma (SEA). Additional large-cohort data are needed…